Drug information

Audio
Brand Name
Complera
Other Names
FTC / RPV / TDF, emtricitabine / rilpivirine / tenofovir, emtricitabine / rilpivirine hydrochloride / tenofovir disoproxil fumarate
Drug Class
Combination Drugs
Non-Nucleoside Reverse Transcriptase Inhibitor (rilpivirine)
Nucleoside Reverse Transcriptase Inhibitor (emtricitabine, tenofovir DF)
Drug Image(s): (Click to enlarge)
Chemical Image: (Click to enlarge)

emtricitabine

Molecular Weight: 247.249

rilpivirine hydrochloride

Molecular Weight: 402.8871

tenofovir disoproxil fumarate

Molecular Weight: 635.5166

FDA label informationFDA label information

Several FDA-approved drug labels may be available for emtricitabine / rilpivirine / tenofovir disoproxil fumarate. Clinical Info provides the following link to the DailyMed drug label solely as an example of the labels available for emtricitabine / rilpivirine / tenofovir disoproxil fumarate. Inclusion or absence of a drug label link on the Clinical Info site does not imply endorsement or lack thereof by Clinical Info. Search DailyMed or Drugs@FDA to access more information on emtricitabine / rilpivirine / tenofovir disoproxil fumarate, including additional drug labels and any generic equivalents.

Tablet (film coated)